Publications by authors named "Maria Filkova"

Claim this Profile
D
Does Concomitant Use of Methotrexate with JAK Inhibition Confer Benefit for Cardiovascular Outcomes? A Commentary.
Peter C Taylor, Alejandro Balsa, Anne-Barbara Mongey, Mária Filková, Myriam Chebbah

Rheumatol Ther· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A predictive model for progression to clinical arthritis in at-risk individuals with arthralgia based on lymphocyte subsets and ACPA.
Klára Prajzlerová, Olga Kryštůfková, Nikola Kaspříková, Nora Růžičková, Hana Hulejová

Rheumatology (Oxford)· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative non-pharmacological care for individuals at risk of rheumatoid arthritis.
Javier Courel-Ibáñez, Tomas Vetrovsky, Nora Růžičková, Concepción Marañón, Krzysztof Durkalec-Michalski

Rheumatol Int· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Abatacept inhibits inflammation and onset of rheumatoid arthritis in individuals at high risk (ARIAA): a randomised, international, multicentre, double-blind, placebo-controlled trial.
Juergen Rech, Koray Tascilar, Melanie Hagen, Arnd Kleyer, Bernhard Manger, Maria Filkova

Lancet· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Teleconsultation in rheumatology: A literature review and opinion paper.
Jérôme Avouac, Hubert Marotte, Alejandro Balsa, Myriam Chebbah, Solenn Le Clanche

Semin Arthritis Rheum· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a potential of circulating miRNAs as biomarkers in rheumatic diseases?
Klára Prajzlerová, Ladislav Šenolt, Mária Filková

Genes Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editorial: Osteoarticular-immunological interplay in response to disease and therapy.
Lisa Deloch, Maria Filkova, Michal Tomcik

Front Immunol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pre-clinical phase of rheumatoid arthritis: From risk factors to prevention of arthritis.
Nora Petrovská, Klára Prajzlerová, Jiří Vencovský, Ladislav Šenolt, Mária Filková

Autoimmun Rev· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The dysregulation of monocyte subpopulations in individuals at risk of developing rheumatoid arthritis.
Klára Prajzlerová, Olga Kryštůfková, Martin Komarc, Heřman Mann, Hana Hulejová

Rheumatology (Oxford)· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High miR-451 expression in peripheral blood mononuclear cells from subjects at risk of developing rheumatoid arthritis.
Klára Prajzlerová, Olga Kryštůfková, Petra Hánová, Veronika Horváthová, Monika Gregová

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-35 in idiopathic inflammatory myopathies.
Heřman Mann, Olga Kryštůfková, Josef Zámečník, Jaromír Háček, Hana Hulejová

Cytokine· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
S100A4 is elevated in axial spondyloarthritis: a potential link to disease severity.
Barbora Šumová, Lucie Andrés Cerezo, Hana Hulejová, Klára Prajzlerová, Michal Tomčík

BMC Rheumatol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum visfatin levels in patients with axial spondyloarthritis and their relationship to disease activity and spinal radiographic damage: a cross-sectional study.
Hana Hulejová, Tereza Kropáčková, Kristýna Bubová, Olga Kryštůfková, Mária Filková

Rheumatol Int· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-sectional study of patients with axial spondyloarthritis fulfilling imaging arm of ASAS classification criteria: baseline clinical characteristics and subset differences in a single-centre cohort.
Kristyna Bubová, Šárka Forejtová, Kateřina Zegzulková, Monika Gregová, Markéta Hušáková

BMJ Open· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polypharmacy and Unplanned Hospitalizations in Patients with Rheumatoid Arthritis.
Maria Filkova, João Carvalho, Sam Norton, David Scott, Tim Mant

J Rheumatol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between circulating miRNAs and spinal involvement in patients with axial spondyloarthritis.
Klára Prajzlerová, Kristýna Grobelná, Markéta Hušáková, Šárka Forejtová, Astrid Jüngel

PLoS One· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-20 is triggered by TLR ligands and associates with disease activity in patients with rheumatoid arthritis.
Ladislav Šenolt, Klára Prajzlerová, Hana Hulejová, Barbora Šumová, Mária Filková

Cytokine· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An update on biomarkers in axial spondyloarthritis.
Klára Prajzlerová, Kristýna Grobelná, Karel Pavelka, Ladislav Šenolt, Mária Filková

Autoimmun Rev· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MicroRNA-125b: association with disease activity and the treatment response of patients with early rheumatoid arthritis.
Veronika Hruskova, Romana Jandova, Lucia Vernerova, Herman Mann, Ondrej Pecha, Maria Filkova

Arthritis Res Ther· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin 35 Synovial Fluid Levels Are Associated with Disease Activity of Rheumatoid Arthritis.
Ladislav Šenolt, Barbora Šumová, Romana Jandová, Hana Hulejová, Heřman Mann

PLoS One· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a role of synovial biopsy in drug development?
Maria Filkova, Andrew Cope, Tim Mant, James Galloway

BMC Musculoskelet Disord· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changing clinical patterns in rheumatoid arthritis management over two decades: sequential observational studies.
Aneela N Mian, Fowzia Ibrahim, Ian C Scott, Sardar Bahadur, Maria Filkova

BMC Musculoskelet Disord· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-35 is upregulated in systemic sclerosis and its serum levels are associated with early disease.
Michal Tomcik, Pawel Zerr, Katrin Palumbo-Zerr, Hana Storkanova, Hana Hulejova, Maria Filkova

Rheumatology (Oxford)· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein tyrosine phosphatase nonreceptor type 2: an important regulator of lnterleukin-6 production in rheumatoid arthritis synovial fibroblasts.
Borbala Aradi, Masaru Kato, Maria Filkova, Emmanuel Karouzakis, Kerstin Klein

Arthritis Rheumatol· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pro-inflammatory effects of interleukin-35 in rheumatoid arthritis.
Mária Filková, Zdenka Vernerová, Hana Hulejová, Klára Prajzlerová, David Veigl

Cytokine· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis